A 2014 study revealed that Rac1 P29S expression in melanoma cell lines and in mouse tumor models conferred resistance to RAF and MEK inhibitors97 with overexpression of Rac1 P29S decreasing apoptosis after RAF and MEK inhibitor treatment. Here, MAP2K7 is linked to melanoma.